AvevoRx
AvevoRx is a specialty infusion pharmacy dispensing Alpha-1 antitrypsin, IVIG/SCIG, and TPN therapies, paired with in-home nursing services for chronic and rare disease patients across 45 states plus Washington, D.C.
- Company typePrivate
- Founded2021
- HeadquartersGreensboro, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What AvevoRx does
AvevoRx is a privately held specialty infusion pharmacy headquartered in Greensboro, North Carolina, founded in 2021. The company dispenses high-cost specialty pharmaceuticals—primarily Alpha-1 antitrypsin augmentation therapies, IVIG/SCIG immunoglobulin products, and total parenteral nutrition (TPN)—and pairs dispensing with in-home clinical nursing services for patients with chronic and rare conditions. The operating model combines licensed pharmacy infrastructure (six locations across Greensboro NC, Austin TX, Jasper GA, Muncie IN, Ceres CA, and Fort Lauderdale FL), a 425+ strong clinical workforce (200+ field clinicians and 225+ company-employed nurses), and pharmacy licensure in 45 states plus Washington, D.C., covering approximately 97% of the U.S. population.
AvevoRx holds limited distribution designation for all four FDA-approved Alpha-1 antitrypsin augmentation therapies and serves as a launch partner for Kedrion's QIVIGY brand of IVIG. The company maintains managed care contracts covering 18+ million lives through BCBS affiliates, Cigna, HAP, and PBMs including Capital Rx and Navitus, and operates under URAC and ACHC specialty pharmacy accreditations. Growth has been substantially inorganic, with four acquisitions completed between 2021 and 2026 (Mid Valley Health, Access to Care, Infupharma, Sunrise Rx), producing 2,000%+ cumulative three-year revenue growth and a ~$90 million run rate.
The revenue model spans four streams: specialty drug dispensing (transactional per-script economics), home infusion nursing (managed services), TPN services (managed services), and managed care contracting (long-term payor agreements). AvevoRx is led by five co-founders—Lauren Pumphrey, Eric Hill, Phil Rielly, Robin Johnson, and Courtney Remley—with additional senior leadership across managed care, industry relations, nutrition, nursing, and pharmacy operations.
AvevoRx firmographics
Firmographics- Name
- AvevoRx
- Legal name
- AvevoRx
- Website
- https://avevorx.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- AvevoRx is a specialty infusion pharmacy dispensing Alpha-1 antitrypsin, IVIG/SCIG, and TPN therapies, paired with in-home nursing services for chronic and rare disease patients across 45 states plus Washington, D.C.
- Ownership category
- akta.pro rank
AvevoRx industry classification
Industry- Product category
- Specialty Infusion Pharmacy
- NAICS
- Home Health Care Services (621610), Ambulatory Health Care Services (621)
- SIC
- Services-Home Health Care Services (8082), Services-Health Services (8000)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
- akta.pro secondary industry
- Medication Reconciliation & Skilled Medication Administration (Clinical) (HSABACAH)
Keywords
Where AvevoRx is headquartered
LocationHeadquarters
- HQ city
- Greensboro
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
AvevoRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Specialty Drug Dispensing: Revenue generated from dispensing specialty infusion medications including IVIG, Alpha-1 therapies, TNF blockers, and biologics through licensed pharmacy locations
- Home Nursing Visits: Revenue from in-home infusion nursing services, with over 21,000 nursing visits projected in 2025 representing 70% year-over-year growth
- Total Parenteral Nutrition (TPN): Customized parenteral nutrition solutions for patients with complex gastrointestinal disorders who cannot absorb nutrients through digestive system
- Managed Care Contracts: Revenue from contracted services with health insurers, managed care organizations, PBMs, and payors covering expanded patient populations
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance-dependent specialty infusion services |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
AvevoRx product offering
Product offeringCore offering
AvevoRx is a national independent specialty infusion pharmacy that provides home and ambulatory infusion care for patients with complex chronic conditions. Its core services include immune globulin (IG) therapy, TNF blockers, Alpha-1 proteinase inhibitor augmentation therapy, bleeding disorder management, and total parenteral nutrition (TPN), supported by a 200+ nurse field workforce and six licensed pharmacy locations with sterile compounding clean-room facilities.
Product overview
AvevoRx is a national independent specialty infusion pharmacy provider offering a unified platform of home infusion and specialty pharmacy services for patients with complex, chronic conditions. The core product is specialty infusion pharmacy services, which includes immune globulin (IG) therapy, TNF blockers (infliximab, golimumab), Alpha-1 proteinase inhibitors, bleeding disorder management, and monoclonal antibody treatments. The company operates AvevoRx Nutrition as a dedicated sub-brand for total parenteral nutrition (TPN) services, featuring intestinal rehabilitation programs and nutrition education. Additional services include the Alpha-1 Advocacy Program for patient support and education, in-home nursing/infusion services with over 200 field clinicians, and patient advocate services providing single points of contact throughout the care journey. Treatments are delivered through specialized pharmacy locations, field nurses, and dedicated support staff throughout the United States.
Differentiator
Problem solved
Functional benefit
Products and services
- Specialty Infusion Pharmacy Services National independent specialty infusion pharmacy providing home infusion care for patients with immune deficiencies, autoimmune disorders, Alpha-1 antitrypsin deficiency, inflammatory conditions, bleeding disorders, and other complex chronic conditions; delivered through licensed pharmacy locations and a 225+ nurse field workforce.
- Immune Globulin (IG) Therapy Purified concentration of human antibodies administered via infusion to treat primary and secondary immune deficiencies and autoimmune disorders; delivered at home or in ambulatory settings.
- TNF Blocker Therapy (Infliximab, Golimumab) Monoclonal antibody therapy targeting tumor necrosis factor to suppress inflammation; FDA-approved for ankylosing spondylitis, Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
- Alpha-1 Proteinase Inhibitor Therapy Intravenous augmentation therapy for Alpha-1 Antitrypsin Deficiency (AATD); AvevoRx is the only privately held provider with access to all four FDA-approved Alpha-1 therapies (Glassia, Aralast, Zemaira, and one additional).
- Bleeding Disorder Management Comprehensive care for hemophilia A, hemophilia B, von Willebrand Disease, and additional rare bleeding disorders including Factor VII, Factor XIII deficiencies, and Glanzmann's Thrombasthenia.
- Total Parenteral Nutrition (TPN) Program Specially formulated mixture of nutrients administered intravenously for individuals who cannot absorb nutrients through their digestive system; includes custom HPN solutions and one-to-one counseling for patients with severe GI disorders and Short Bowel Syndrome.
- AvevoRx Nutrition Dedicated nutrition services brand offering home parenteral nutrition support, intestinal rehabilitation programs, and nutrition education through a team of Registered Dietitians, Registered Nurses, and Board-Certified Pharmacists specializing in home TPN.
- Alpha-1 Advocacy Program High-touch nationwide advocacy, education, and patient engagement platform for Alpha-1 Antitrypsin Deficiency patients; includes family and genetic testing coordination, financial assistance navigation, and dedicated patient advocates.
- Home Nursing and Infusion Services In-home infusion therapy administration by trained nurses with self-infusion training options for patients and caregivers; projected 21,000+ nursing visits in 2025 with over 200 field clinicians across multiple states.
- Patient Advocate Services Single point of contact patient advocates who help navigate insurance authorizations, treatment options, and therapy management, and coordinate between patients, providers, and payers.
Quantifiable outcome
- 96% year-over-year revenue growth in FY2024
- +4 more outcomes
Companies that use AvevoRx
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles6 records
AvevoRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
AvevoRx partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and strategic.
- Sunrise Rx (Acquisition)coreAcquisition of Sunrise Rx, a Long Island-based specialty infusion pharmacy, expanding AvevoRx's presence across New York, New Jersey, Connecticut, and New Hampshire. Founded by Rich Collins and Dan Manchise.
- Kedrion BiopharmacoreAvevoRx selected as network specialty pharmacy to support U.S. launch of QIVIGY, Kedrion's newly approved 10% IVIG therapy. AvevoRx positioned among select group of specialty pharmacies participating in the nationwide launch, integrating QIVIGY into its growing portfolio of specialty infusion therapies.
- Blue Cross Blue Shield AffiliatescoreManaged care partnerships with regional BCBS plans in Illinois, Pennsylvania, Western and Northeastern New York, New Jersey, and North Carolina, extending coverage to 18 million additional covered lives.
- Cigna Healthcare of CaliforniacoreManaged care partnership with Cigna Healthcare of California for specialty infusion services.
- HAP MichigancoreManaged care partnership with HAP in Michigan for specialty infusion services.
- Capital Rx, Navitus, Abarca Health, SavRx, Maxor PlusstrategicPartnerships with innovative small-to-medium-sized PBMs disrupting the industry status quo, enabling AvevoRx to introduce its high-touch model to employers and plan sponsors seeking flexible care solutions.
- Global Healthcare Company (Alpha-1 Drug Manufacturer)coreLimited distribution agreement for an Alpha-1 proteinase inhibitor (human) completing AvevoRx's suite of treatment offerings for all four FDA-approved Alpha-1 therapies. Agreement grants distribution rights for drugs treating Alpha-1 antitrypsin deficiency (AATD).
- The Oley FoundationcoreCorporate sponsorship partnership with the nonprofit Oley Foundation to support thousands of individuals requiring specialized home parenteral nutrition services. $25,000 contribution as part of national effort to provide home nutrition support services for complex GI conditions.
Scale indicators14 records
Recent moves12 records
Expansion highlights5 records
AvevoRx competitors and assessment
Company assessmentDirect peers
- Nufactor: Specialty infusion pharmacy focused on immune globulin and biologic therapies for primary immune deficiency, autoimmune, and inflammatory conditions. Direct competitor in IVIG/SCIG and immune therapy home infusion with similar patient advocacy focus.
- BioPlus Specialty Pharmacy: Specialty pharmacy focused on complex conditions including immune deficiencies, autoimmune disorders, and rare diseases. Now a subsidiary of Elevance Health but historically operated as a direct competitor in IVIG, Alpha-1, and biologic infusion therapy distribution.
- Option Care Health: Largest independent provider of home and alternate-site infusion services in the US, publicly traded (Nasdaq: OPCH). Direct competitor across home infusion therapy delivery, including specialty biologics, with national scale and similar payer contract model.
- Soleo Health: Private specialty infusion pharmacy and home infusion services provider focused on IVIG, Alpha-1, immunoglobulin, and biologic therapies. Directly comparable in therapy mix, home nursing model, and specialty pharmacy positioning.
- PromptCare: National specialty home infusion provider offering IVIG, biologics, TPN, and home infusion nursing services. Comparable in therapy breadth, geographic coverage, and high-touch patient care model serving chronic complex conditions.
- CSI Pharmacy: Specialty infusion pharmacy focused on IVIG, Alpha-1, and biologic therapies with home and infusion suite administration. Comparable therapy mix, Alpha-1 program emphasis, and home nursing model.
Broad incumbents
- BrightSpring Health Services: Public diversified home and community-based health services platform (Nasdaq: BTSG) with pharmacy, infusion, and home health segments. Overlaps with AvevoRx's specialty infusion and home nursing model but operates across broader service lines.
- Coram CVS Specialty Infusion Services: National home infusion and specialty pharmacy division of CVS Health. Offers overlapping IVIG, TPN, and biologic infusion capabilities but operates as part of CVS's broader retail, PBM (Caremark), and healthcare portfolio rather than as an independent specialty.
- Walgreens Specialty Pharmacy: Specialty pharmacy division of Walgreens Boots Alliance offering infusion, injectable, and complex therapy management. Competes broadly in specialty drug distribution but lacks AvevoRx's focus on independent, conflict-free home infusion positioning.
- Diplomat Specialty Pharmacy (OptumRx): Specialty pharmacy now operating within OptumRx/Optum (UnitedHealth Group). Historically a leading independent specialty pharmacy competing in rare disease, oncology, and infusion therapies before acquisition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
AvevoRx social profiles
Digital presenceAvevoRx compliance and trust
Trust signalCompliance3 records
AvevoRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
AvevoRx leadership team
Management profileNumber of profiles
Profiles12 records
AvevoRx subsidiaries and ownership
Company hierarchySubsidiaries5 records
AvevoRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AvevoRx M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AvevoRx
What does AvevoRx do?
AvevoRx is a national independent specialty infusion pharmacy that provides home and ambulatory infusion care for patients with complex chronic conditions. Its core services include immune globulin (IG) therapy, TNF blockers, Alpha-1 proteinase inhibitor augmentation therapy, bleeding disorder management, and total parenteral nutrition (TPN), supported by a 200+ nurse field workforce and six licensed pharmacy locations with sterile compounding clean-room facilities.
Is AvevoRx a public or private company?
AvevoRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AvevoRx founded?
AvevoRx was founded in 2021. It employs 101 to 250 people.
Where is AvevoRx based?
AvevoRx is headquartered in Greensboro, United States, in the North America region.
How does AvevoRx make money?
Four revenue lines are on record. Specialty Drug Dispensing is the primary driver. The others are home Nursing Visits, total Parenteral Nutrition (TPN) and managed Care Contracts.
Who are AvevoRx's main competitors?
Direct peers on record are Nufactor, BioPlus Specialty Pharmacy, Option Care Health, Soleo Health, PromptCare and CSI Pharmacy. Broad incumbents are BrightSpring Health Services, Coram CVS Specialty Infusion Services, Walgreens Specialty Pharmacy and Diplomat Specialty Pharmacy (OptumRx).
Does AvevoRx have an API?
No public API is recorded for AvevoRx.
What industry is AvevoRx in?
AvevoRx's product category is Specialty Infusion Pharmacy. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HSABACAH, Medication Reconciliation & Skilled Medication Administration (Clinical). Its NAICS code is 621610 and its SIC code is 8082.